June 16, 2026 Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
June 16, 2026 RGC INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of the June 23, 2026 Lead Plaintiff Deadline in the Regencell Bioscience Holdings Limited Securities Class Action
June 16, 2026 ZSPC INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of the June 22, 2026 Lead Plaintiff Deadline in the zSpace, Inc. Securities Class Action
June 16, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against ADMA Biologics, Inc. (ADMA), Erasca, Inc. (ERAS), and Nano-X Imaging Ltd. (NNOX) Announced by Holzer & Holzer, LLC
